1. Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease
- Author
-
Nadia Peragine, Francesca Rossi, Paola Mariglia, Caterina Ilari, Chiara Favini, Giovanni Del Poeta, Silvia Bonina, Luca Vincenzo Cappelli, Francesca Romana Mauro, Marilisa Marinelli, Fary Diop, Ilaria Del Giudice, Alfonso Piciocchi, Sara Raponi, Gian Matteo Rigolin, Valter Gattei, Davide Rossi, Riccardo Bomben, Monica Messina, Anna Guarini, Antonio Cuneo, Luciana Cafforio, Robin Foà, Gianluca Gaidano, and Michele Dal Bo
- Subjects
Adult ,Male ,Chronic lymphocytic leukaemia ,DNA Mutational Analysis ,Aggressive disease ,In situ hybridization ,NO ,03 medical and health sciences ,BIRC3 biallelic inactivation ,0302 clinical medicine ,Humans ,Medicine ,Digital polymerase chain reaction ,Allele ,Alleles ,In Situ Hybridization, Fluorescence ,Aged ,Sequence Deletion ,BIRC3 Gene ,Aged, 80 and over ,Chromosome Aberrations ,Lymphocytic leukaemia ,business.industry ,Chromosomes, Human, Pair 11 ,11q deletion ,BIRC3 gene ,Hematology ,Middle Aged ,medicine.disease ,Prognosis ,Leukemia, Lymphocytic, Chronic, B-Cell ,Droplet digital PCR ,Baculoviral IAP Repeat-Containing 3 Protein ,Leukemia ,030220 oncology & carcinogenesis ,Cancer research ,outcome ,chronic lymphocitic leukemia ,Female ,business ,Follow-Up Studies ,030215 immunology - Published
- 2018